Chemical Property of Enisamium iodide
Chemical Property:
- PSA:20.95000
- LogP:3.22340
- Hydrogen Bond Donor Count:1
- Hydrogen Bond Acceptor Count:2
- Rotatable Bond Count:3
- Exact Mass:354.02291
- Heavy Atom Count:18
- Complexity:241
- Purity/Quality:
-
99%, *data from raw suppliers
AMIZON 95.00% *data from reagent suppliers
Safty Information:
- Pictogram(s):
- Hazard Codes:
- MSDS Files:
-
SDS file from LookChem
Useful:
- Canonical SMILES:C[N+]1=CC=C(C=C1)C(=O)NCC2=CC=CC=C2.[I-]
- Recent ClinicalTrials:A Clinical Study to Assess the Efficacy and Safety of Amizon? Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus
- Recent EU Clinical Trials:A Phase II, multicenter, multinational, randomized, double-blinded, placebo-controlled dose-finding study to evaluate the efficacy and safety of carbabenzpyride in the treatment of uncomplicated influenza A.
-
Uses
1-Methyl-4-[[(phenylmethyl)amino]carbonyl]pyridiniumiodide (CAS# 201349-37-3) is Enisamium iodide (Amizon?, Farmak) is approved for clinical use in the treatment of influenza in 11 countries which includes Ukraine, Russia, Belarus, Kazakhstan, and Uzbekistan. Enisamium iodide exhibited antiviral activity against influenza viruses in vitro, supporting the reported clinical efficacy against influenza virus infections.